Sam Brusco, Associate Editor06.21.22
Manufacturing partner ATL Technology has acquired BioVision Technologies, a developer of disposable scopes for in-office arthroscopy and TMJ procedures, as well as disposable catheter systems for epidural and sinus procedures.
“This strategic acquisition supports the expansion of our medical imaging and access business unit, more specifically, the development and manufacture of single use minimally invasive procedural devices. Incorporating BioVision’s 30 years of endoscopy and medical industry expertise with disposable scopes will give us the opportunity to closely partner with our customers and offer the complete solutions they require,” Brad Brown, CEO of ATL told the press.
ATL will fully integrate BioVision’s capabilities into its current range of development and full-service manufacturing offerings. BioVision founder Dave Sanso will continue as Imaging Innovation and Devleopment Fellow, supporting the minimally invasive business unit with focus on imaging and access devices needing camera modules for guidance and imaging.
“The demand for single-use camera-based scopes and devices is greater now than it has ever been. We originated the PREVOYANCE plug and play camera assembly as a starting point for engineers to design cameras into next gen imaging devices. The inclusion of the BioVision camera control unit / image signal processor into the PREVOYANCE family of products, enables ATL the ability to provide our joint development and manufacturing partners a complete imaging system for their products. Incorporating Dave and his years of expertise into ATL’s engineering team is an enormous benefit to ATL.” said Mike Anderson, managing director, Imaging and Access Business Unit.
“This strategic acquisition supports the expansion of our medical imaging and access business unit, more specifically, the development and manufacture of single use minimally invasive procedural devices. Incorporating BioVision’s 30 years of endoscopy and medical industry expertise with disposable scopes will give us the opportunity to closely partner with our customers and offer the complete solutions they require,” Brad Brown, CEO of ATL told the press.
ATL will fully integrate BioVision’s capabilities into its current range of development and full-service manufacturing offerings. BioVision founder Dave Sanso will continue as Imaging Innovation and Devleopment Fellow, supporting the minimally invasive business unit with focus on imaging and access devices needing camera modules for guidance and imaging.
“The demand for single-use camera-based scopes and devices is greater now than it has ever been. We originated the PREVOYANCE plug and play camera assembly as a starting point for engineers to design cameras into next gen imaging devices. The inclusion of the BioVision camera control unit / image signal processor into the PREVOYANCE family of products, enables ATL the ability to provide our joint development and manufacturing partners a complete imaging system for their products. Incorporating Dave and his years of expertise into ATL’s engineering team is an enormous benefit to ATL.” said Mike Anderson, managing director, Imaging and Access Business Unit.